18 May 2013
Keywords: gsk, recalls, lapdap, halts, dacart, uk-based, drug
Article | 10 March 2008
UK-based drug major GlaxoSmithKline is to stop selling the malaria drug Lapdap (chlorproguanil/dapsone) after study data revealed that its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2008
17 May 2013
© 2013 thepharmaletter.com